Industry News

• FDA launches new organizational performance management system   The FDA launched an innovative performance management system designed to advance transparency, public participation, and collaboration. The system, called FDA-TRACK, will monitor more than 100 FDA program offices through data from key performance measures established each year.
  U.S. Food and Drug Administration September 01, 2010  
• NIAID Grant to Fund Dynavax Research on Hepatitis B Vaccination and Individual Variations   Dynavax announced a grant from NIAID to take a systems biology approach to study the differences between individuals that do or do not respond to vaccination against the Hepatitis B virus. This study will be one of several projects covered in a five-year, $17.6 million grant to Baylor Institute.
  Dynavax Technologies Corporation August 31, 2010  
• Monsanto projects solid conclusion of fiscal year  Monsanto Company confirmed the drivers of its fourth-quarter operating plan have tracked well with management expectations, positioning the company to conclude the fiscal year within its previous guidance ranges for ongoing earnings per share (EPS) and free cash flow.
  Monsanto Company August 31, 2010  
• Pivotal Phase 3 study compares tapentadol extended release tablets to placebo  Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation.
  Johnson & Johnson August 30, 2010  
• NIH Loan Repayment Programs relieve researchers' educational debt   As medical education costs rise, NIH Loan Repayment Programs have, for nearly 10 years, supported early stage investigators by repaying up to $35,000 of educational debt annually for investigators who commit to at least two years of research funded by a U.S. nonprofit, university or government body.
  National Institutes of Health August 30, 2010  
• Albemarle names Karen G. Narwold Senior Vice President and General Counsel  Albemarle Corporation announced that Karen G. Narwold has joined the company as Senior Vice President and General Counsel. Ms. Narwold will assume responsibility for all legal matters related to the corporation on September 13, 2010.
  Albemarle Corporation August 30, 2010  
• Viruses found in chronic fatigue syndrome patients  New research supports the idea that viruses may play a role in chronic fatigue syndrome (CFS), a debilitating disease that affects millions of people nationwide.
  National Institutes of Health August 30, 2010  
• Albemarle increases prices of FCC catalysts and implements rare earth surcharges  Albemarle will increase prices of FCC catalysts by 10% globally, effective October 1, 2010, or as contracts allow. In addition, Albemarle will implement rare earth surcharges on FCC catalysts and additives, effective October 1, 2010.
  Albemarle Corporation August 30, 2010  
• BARDA funds $27 million drug development for biothreats, antibiotic resistance to Achaogen  HHS has awarded a contract to develop an antibiotic that could be used against possible two types of bioterrorism and common infections becoming resistant to antibiotics. The contract to Achaogen of San Francisco is for $27 million in the first two years, and can be extended for three years.
  U.S. Dept of Health & Human Services August 30, 2010  
• Texas investment to help those with kidney, liver disease  Gov. Rick Perry announced a $2 million investment through the Texas Emerging Technology Fund in ZS Pharma, Inc., for the development of its therapeutic solution for the treatment of complications associated with liver and kidney failure.
  State of Texas, Office of the Governor August 30, 2010  

(previous 10 articles)    (next 10 articles)